Should Patients With Ocular Myasthenia Gravis Be Started on Immunosuppression to Prevent Generalization?

Half a century of change: demographic trends and their clinical impact in acetylcholine receptor antibody-positive myasthenia gravis.

On the increased prevalence of myasthenia gravis in patients with inflammatory bowel disease.

Beyond numbers: challenges in assessing myasthenia gravis prevalence in inflammatory bowel disease.

Pediatric Myasthenia Gravis.

Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis.

Case Report: Dual response to efgartigimod in myasthenia gravis and comorbid autoimmune disorders: a case series.

From Limited Samples to Mechanistic Insights: Exploratory Identification and Functional Validation of a hsa_circ_0062400/hsa_circ_0002397-miR-338-3p-NRP1 Axis in Myasthenia Gravis.

Bridging the gap between patient and physician perspectives on management of generalized myasthenia gravis: a Delphi consensus study.

The Effect of Thymectomy on the Incidence of Extrathymic Cancers and Autoimmune Diseases in Patients With Non-Thymomatous Myasthenia Gravis.

Burden of glucocorticoid use in commercially insured adults with generalized myasthenia gravis in the United States: A retrospective claims-based analysis.

Hsa_circ_0000313/miR-1224-3p/MKNK2 Axis Modulates CD4+ T Cells by Activating p38 MAPK Signaling in Myasthenia Gravis.

Very Late-Onset Generalized Myasthenia Gravis Presenting With Worsening Frailty.

Neuro-immune interactions underlying autoimmune diseases: insights from brain imaging data.

Italian recommendations for the diagnosis and treatment of myasthenia gravis.

Morvan syndrome in a patient with progressing metastatic thymoma and myasthenia gravis.

Risk of New-Onset Myasthenia Gravis Following COVID-19 Infection and Vaccination: A Population-Based Case-Control Study.

Minimal Symptom Expression in Generalized Myasthenia Gravis: A Valuable Patient-Centric Treatment Goal.

Effectiveness and Safety of Eculizumab in Highly Active AChR+gMG and Its Therapeutic Response in Different Subtypes of gMG.

Letter regarding impact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans Affairs Health Network.

Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy.

Sexual health in neuromuscular diseases: Neglected challenges revealed by a scoping review.

Neurological immune-related adverse events of immune-checkpoint inhibitors: an updated review.

SEC-based isolation of phosphatidylserine-liposomes from biological samples for preclinical studies.

Double-Filtration Plasmapheresis Versus Efgartigimod for Generalized Myasthenia Gravis: Severity-Stratified Benefits in a Prospective Observational Multicenter Study.

A high-throughput screening platform for acetylcholinesterase inhibitors using a genetically encoded acetylcholine fluorescent sensor.

The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis.

Comorbidities and Treatment Patterns in People With Myasthenia Gravis in Denmark, Finland and Sweden: A Population-Based Observational Study.

Clinical and quality-of-life outcomes associated with efgartigimod in patients with generalized myasthenia gravis transitioning from intravenous immunoglobulin.

Co-occurrence of systemic lupus erythematosus and myasthenia gravis: Insights from a cross-sectional cohort.

When Central Tolerance Fails: Thymic Malignancies at the Intersection of Cancer Immunity and Autoimmunity.

Shared genetic and neuroimmune architecture links type 1 diabetes with neurocognitive traits.

Association between obesity and subsequent risk of myasthenia gravis: a nationwide population-based cohort study.

Estimating the minimal clinically important difference for the Myasthenia Gravis Quality of Life revised scale (MG-QOL15R).

Who Can Safely Discontinue Treatment in Myasthenia Gravis? Insights From a Long-Term Real-World Study.

A Decade of Surgical Management of Thymic Tumours in Western Australia.

Old Foundations in a New Era of Myasthenia Gravis Therapy.

Analysis of adverse drug reactions associated with ravulizumab: a retrospective pharmacovigilance study utilizing the FAERS database.

Neuro-ophthalmic presentation of leptomeningeal metastasis of thymoma: a case report.

CAR T cell therapy in autoantibody-mediated neurological disorders: a promising strategy.

Elucidating genetic backgrounds of myasthenia gravis in Japanese by genome-wide association studies and multi-omics analyses of thymoma.

Myasthenic Crisis Unmasking Myocardial Infarction with Nonobstructive Coronary Arteries in a Patient with Undiagnosed Myasthenia Gravis.

Indirect Comparison of Nipocalimab Versus Efgartigimod and Rozanolixizumab in the Treatment of Generalized Myasthenia Gravis.

Juvenile Myasthenia Gravis: An Indian Perspective.

Advantages of negative-pressure suction device compared to traditional chest closed drainage in the management of patients after mediastinal mass resection.

Concurrent Nivolumab-Induced Myocarditis and Myasthenia Gravis: A Case Report.

Isolated dysphagia masking myasthenia gravis diagnosis.

[Clinical characteristics and genetic analysis of a patient with Kennedy disease with secondary infertility as the initial symptom].

Case Report: Positioning head tilt observed in six dogs with meningoencephalitis of unknown origin.

Application of Droplet Digital PCR in Sputum Samples in Myasthenia Gravis Patients with Pneumonia.

Late-Onset Ocular Myasthenia Gravis-Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report.

Single-stage concomitant extended thymectomy for myasthenia gravis and enucleation of a left recurrent laryngeal nerve schwannoma via median sternotomy.

Caring beyond the procedure: a qualitative study on thoracic surgery nurses' perspectives on chronic illness experiences of individuals with myasthenia gravis undergoing thymectomy.

Quality and reliability of myasthenia gravis-related short videos on TikTok and Bilibili: A cross-sectional study.

Clinical and electrophysiological characteristics of myasthenia gravis patients with concomitant type 2 diabetes mellitus.

Cholinergic Crisis Associated With Standard-Dose Pyridostigmine in a Hemodialysis Patient With Ocular Myasthenia Gravis and Marked Weight Loss.

Seizure as an Atypical Presentation of Myasthenia Gravis: A Rare but Critical Diagnostic Challenge.

Astragaloside IV ameliorates experimental autoimmune myasthenia gravis through multi-target regulation of immune-microbiota-metabolism network and ferroptosis inhibition.

Experience Using Efgartigimod to Treat Juvenile Myasthenia Gravis in China: A Multicenter Retrospective Study.

Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients-A Population-Based, Matched Case-Control Study.

Clinical and economic outcomes of therapeutic plasma exchange and intravenous immunoglobulin for treating adults with autoimmune neurological disorders: a systematic review and meta-analysis.

Cloudy or Clear? Readability and Content Analysis of Patient Education Materials in Myasthenia Gravis.

Myasthenia gravis and pregnancy: a systematic review and meta-analysis.

Efficacy and safety of telitacicept for myasthenia gravis in real-world practice and exploratory outcomes in the elderly subgroup.

Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 results.

[Diagnosis of myasthenia gravis in a patient with polymyositis].

Physical and respiratory training in patients with myasthenia gravis: a systematic review with meta-analysis.

Early-Onset Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Following First-Cycle Pembrolizumab: Diagnostic Challenges and Management Strategies.

Rapidly Progressive Overlap of Immune Checkpoint Inhibitor-Induced Myositis and Myasthenia Gravis: Diagnostic and Therapeutic Challenges.

Non-Motor Symptoms in Myasthenia Gravis Patients: Evaluation of Auditory and Olfactory Functions.

Evaluation of Muscle Oxygenation by Functional Near-Infrared Spectroscopy in Patients with Myasthenia Gravis During Rest and Exercise.

Elevated serum Interleukin-39 in Myasthenia gravis: a possible biomarker.

Distinguishing pharmacological toxicity from disease severity and lifestyle confounders in myasthenia gravis comorbidity models.

Giant cell myositis confined to the lower extremities without associated thymoma or myasthenia gravis: a case report.

Efficacy and safety of immunosuppressants and immunomodulators in juvenile myasthenia gravis: a systematic review and meta-analysis.

Zilucoplan is effective for ravulizumab-refractory generalized myasthenia gravis with the C5 p.Arg885His variant: a case report.

Robot-assisted versus video-assisted surgery for early functional recovery in patients with non-small-cell lung cancer: a systematic review and meta-analysis of propensity score-based matching studies.

Effective Use of the Thoracolumbar Interfascial Plane Block With Total IV Anesthesia for Laminoplasty in a Patient With Myasthenia Gravis: A Case Report.

Rapid Symptomatic Improvement and Long-Term Minimal Symptom Expression in a Myasthenia Gravis Patient Treated With Zilucoplan Without Maintenance Cholinesterase Inhibitors, Corticosteroids, or Immunosuppressants: A Case Report.

Emergency use of eculizumab in impending and manifest myasthenic crisis: a retrospective case series.

Miglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease.

The temporal sequence of myasthenia gravis and neuromyelitis optica spectrum disorder: a case report and systematic review of 74 patients.

Real-World Evaluation of Efgartigimod in Generalized Myasthenia Gravis: A Single-Center Experience.

A Novel Truncating Pathogenic Variant in RRM2B in a Kurdish Family With Autosomal-Dominant Chronic Progressive External Ophthalmoplegia Plus (PEOA5).

Isolated bilateral facial palsy as the initial presenting manifestation of generalized myasthenia gravis preceding myasthenic crisis.

Successful prehospital resuscitation of a young female patient with myasthenia gravis experiencing cardiopulmonary arrest due to complete airway obstruction: a case report and review of the literature.

Triple M syndrome (myasthenia gravis, myocarditis and myositis) following atezolizumab in small cell lung carcinoma.

Rethinking rituximab in neuroimmunology: Real-world efficacy, cost-effectiveness, and long-term remission.

Progress in the Treatment of Refractory Myasthenia Gravis.

The Relationship Between Immune Semaphorins and Myasthenia Gravis.

Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study.

Single-cell RNA-sequencing of myasthenia gravis reveals transcriptional heterogeneity and dysfunction of immune cell populations.

Association between vaccination and myasthenia gravis: a systematic review and meta-analysis.

Adverse Childhood Experiences and Psychological Health in Patients with Myasthenia Gravis: A Study Incorporating an Online Positive Mental Health Learning Program.

Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy.

Current status and challenges of biologic targeted therapy for myasthenia gravis in China.

Case Report: Thymoma-associated myasthenia gravis, myositis, myocarditis, and anti-GAD65 autoimmune encephalitis: a unique case of paraneoplastic polyautoimmunity.

Safety and Effectiveness of Eculizumab in Patients With Refractory Ocular or Ocular-Predominant Myasthenia Gravis: A Case Series.

Immunotherapy Safety in Thymic Epithelial Tumors: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System.

Clinical course and prognosis of chronic autoimmune neuropathies requiring intensive care: a retrospective cohort study.

A comprehensive electrooculography measurement system and protocols for screening myasthenia gravis.

Telitacicept for refractory AChR-positive generalized myasthenia gravis: a retrospective real-world study.

Outcomes of preoperative medical consultations for elective non cardiac surgical procedures at tertiary care center.

Simultaneous Diagnosis of Myasthenia Gravis and Neurosyphilis, With Symptoms Improving After Neurosyphilis Treatment: A Case Report.

High expression of IRF8 in AChR-specific cells regulates the function of B cells.

Are you weary of illness? Coping and existential positioning in life with myasthenia gravis.

Real-World Outcomes of Efgartigimod in Adult Myasthenia Gravis.

Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study.

Immune Dysregulation: Navigating Autoimmune Disorders in Exotic Companion Animals.

Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD.

Pregnancy and antibody-mediated diseases: evidence and gaps.

[A drooping gaze, a cold clue: Late-onset presentation of myasthenia gravis].

Patient Perceptions of Needs and Expectations Regarding the Current Management of Myasthenia Gravis: A Biopsychosocial Study.

Myasthenia Gravis With Acetylcholine Receptor Antibodies in the Very Old: Treatment Challenges and Diagnostic Pitfalls.

Combined adapted physical activity and art-therapy intervention in myasthenia gravis: Study protocol for a randomized crossover pilot trial.

Low Prevalence and Inconsistency of LRP4-IgG Detection in Suspected Myasthenia Gravis: A Multicenter CBA Comparison.

Nationwide trends in mediastinal tumor and myasthenia gravis surgery in Japan: a decade claims-based analysis (2014-2023).

Outcomes following single-level lumbar fusion in patients with myasthenia gravis.

The role and mechanism of IL‑35 in myasthenia gravis (Review).

Assessment of Voice and Speech attributes in Adult Patients with Myasthenia Gravis. A case control study.

Inflammatory biomarker panels in peripheral blood: association with myasthenia gravis onset and severity.

Monocyte-macrophage SAMHD1 alleviates EAMG by modulating the cGAS-STING pathway.

Qiangji Jianli Decoction attenuates skeletal muscle injury in rats with experimental autoimmune myasthenia gravis via the GRP78/IRE1α/GPX4 signaling pathway.

Clinical response to therapeutic plasma exchange in patients with immune-mediated inflammatory diseases of the central nervous system.

The Duke MG Patient Registry III. Comparative Effectiveness of Azathioprine and Mycophenolate Mofetil in Generalized Myasthenia Gravis, a Retrospective Single Center Review.

First Paediatric Case of mRNA COVID-19 Vaccine Associated New Onset Systemic Myasthenic Crisis.

Clinical outcomes, serum IgG changes, and follow-up observations in the treatment of anti-AChR antibody-positive generalized myasthenia gravis with Efgartigimod.

Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study.

[Is it myasthenia gravis?].

Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB-IV melanoma (KEYVIBE-010): a randomised, double-blind, phase 3 study.

Thymectomy with or without maintenance therapy for myasthenia gravis patients: a tri-center, real-world study.

Case-Based Lessons on Remote Patient Monitoring in Neurology Using Consumer-Grade Wearables.

Genetic insights into biological aging and myasthenia gravis: a Mendelian randomization study of telomere length, epigenetic clocks, and mitochondrial DNA copy number.

Docosahexaenoic acid supplementation aggravates myasthenia gravis through immune dysregulation.

Mendelian randomization followed by single-cell RNA sequencing exploration identifies effector memory CD4+ T cells as a risk factor for myasthenia gravis.

Factors Influencing the Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis: A Retrospective Cohort Study.

C-Reactive Protein and Neurological Autoimmune Diseases: Bridging the Diagnostic and Pathogenic Gap.

Long-Term Response Without Immune-Related Adverse Events to Atezolizumab Treatment in TMB-High Thymoma: A Case Report from the KOSMOS-II Study.

Perceived Fatigue and Associated Psychological Factors in Patients with Myasthenia Gravis.

Associations between myasthenia Gravis and outcomes following cardiac surgery: an analysis of the nationwide inpatient sample.

Takotsubo cardiomyopathy in myasthenia gravis: a systematic review of case reports with subtype-based analysis.

Postoperative hormonal modulation in a patient with granulosa cell tumor and myasthenia gravis: a gyneco-oncologic perspective.

Telitacicept demonstrates high probability of efficacy in myasthenia gravis: a Bayesian real-world study.

Immuno-deficient features of thymoma-associated myasthenia gravis patients with hypogammaglobulinemia: A condition comparable to Good's syndrome.

Associated Autoimmunity in Myasthenia Gravis in Denmark: A Nationwide Case-Control Study.

Diphtheria Presenting With Cranial Neuropathy: The Patch Unseen.

The Differential Diagnosis of Diplopia.

Application analysis of transfected cell method for detecting AChR antibodies in MG patients.

Acute Myasthenic-Like Illness: A Common Presentation of Neurotoxic Snakebite in a Tropical Region.

Immune Checkpoint Inhibitor-Related Myositis and Associated Triad Overlap Syndrome.

Diagnostic performance and safety of the edrophonium test in myasthenia gravis: a retrospective case-control study.

Comparative outcomes of robotic- and video-assisted thoracoscopic surgery in thymectomy: a systematic review of implications for myasthenia gravis remission and long-term oncology.

AI-driven biomarker learning for the early diagnosis of neurodegenerative diseases: ABLEDx.

Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis.

Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis.

Letter to editor: Early real-life experience on zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Real-world use of efgartigimod in acetylcholine receptor antibody-positive generalized myasthenia gravis: experience from two centers in Greece and Cyprus.

Myasthenia gravis following the initiation of statin therapy: A multinational self-controlled case series study.

Fusion of deep learning and radiomics with dynamic spatiotemporal modeling for non-small cell lung cancer recurrence risk assessment after microwave ablation.

Incidence and clinical characteristics of concurrent thyroid eye disease and ocular myasthenia gravis.

Global Research Landscape in T Cells and Myasthenia Gravis: Trends, Collaborations, and Future Directions.

Multisystemic Malakoplakia Revealed by 18F-FDG PET/CT: A Case of Concomitant Bilateral Osteomyelitis and Genitourinary Involvement.

Incidental finding of "H"-type duplex gallbladder: a case report.

Evaluation of neuromuscular blocker use in myasthenia gravis patients undergoing rapid sequence intubation.

Neurologists' decision-making in the management of generalised myasthenia gravis: Therapeutic inertia and treatment choices.

Delayed recovery following myasthenic exacerbation and subsequent endplate-protecting treatment.

Frequent co-occurrence of AChR-positive myasthenia gravis in facioscapulohumeral muscular dystrophy suggests a novel disease association.

Improved Neuromuscular Transmission Following Thymectomy in Juvenile Myasthenia Gravis: A Case Series.

Successful use of immune checkpoint Inhibition in a patient with myasthenia gravis and recurrent endometrial cancer- expanding access beyond initial clinical trial eligibility.

Safety of home administration of cipaglucosidase alfa plus miglustat in late-onset Pompe disease: results from multiple clinical trials.

Electrodiagnostic Approach to Defects of Neuromuscular Transmission.

[Myasthenic syndromes: retrospective analysis of two patient cohorts].

Rozanolixizumab-induced aseptic meningitis in AChR-thymoma associated myasthenia gravis.

Corticosteroid-Refractory Juvenile Myasthenia Gravis: Treatment Responses and Prognosis in a Large Chinese Cohort.

Clinical characteristics and treatment outcomes in thymoma- related aplastic anemia: a case report and literature review.

Serum from patients with acetylcholine receptor antibody-positive myasthenia gravis triggers pathogenic changes in human myotube cells.

Low-dose IL-2 Ameliorates Experimental Autoimmune Myasthenia Gravis in Rats by Restoring the CD4-positive Helper T-cell Balance Via the JAK/STAT5 Pathway.

Iatrogenic botulism: a risk for botulinum toxin's medical use?

Fc receptor-like proteins and their role in B-cell responses and autoimmune diseases.

Multi-omics profiling reveals intrathymic triggers and novel biomarkers in thymoma-associated myasthenia gravis.

Efgartigimod for steroid-resistant autoimmune glial fibrillary acidic protein astrocytopathy: a case report and literature review.

ENGAGE: Analyzing the value of virtual reality in a patient-centric immersive learning program in myasthenia gravis for healthcare professionals.

Azathioprine Toxicity in Patients With Myasthenia Gravis: A Single Center Experience.

Exploring the impact of age of onset on stereoacuity in patients with myasthenia gravis.

The rare report of unicentric Castleman disease with concurrent myasthenia gravis and paraneoplastic pemphigus: a case report with a focused review of the literature.

Fracture Occurrence Within FRAX-Defined High-Risk Myasthenia Gravis: An Exploratory Stratification by Age and Activities of Daily Living.

A Shift from Standard Median Sternotomy to Robotic-Assisted Thoracic Surgery for Resection of Anterior Mediastinal Tumors.

Gut Microbiota as Neuroimmune Modulators in Myasthenia Gravis: Mechanistic Insights from the Gut-Brain Axis to Therapeutic Innovations.

Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis.

1-Year Clinical Outcome Post-Myasthenic Crisis: A Multicenter Prospective Study in China.

Aberrant expression of triggering receptor expressed on myeloid cell-1 is involved in the immunopathological mechanism of myasthenia gravis.

Add-on efgartigimod in myasthenic crisis: a promising treatment option.

Efgartigimod combined with rituximab helps improve the symptoms and reduce the use of corticosteroids in patients with MuSK antibody-positive MG: a single case report.

Exploring Pembrolizumab-Induced IM3OS in a Patient With Bladder Cancer.